|
Re: $2.72 just 4 more cents for a new 52 week high....
|
1
|
Resverlogix Corp.
|
Jul 11, 2018 11:36AM
|
|
Re: Bioasis & BioAgilytix Announce Strategic Partnership to Advance xB3-001
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 11, 2018 01:29PM
|
|
Kidney Trial
|
5
|
Resverlogix Corp.
|
Jul 11, 2018 01:54PM
|
|
Re: Now that we're a small cap stock....
|
5
|
Resverlogix Corp.
|
Jul 12, 2018 09:41AM
|
|
Re: Now that we're a small cap stock....
|
8
|
Resverlogix Corp.
|
Jul 12, 2018 12:10PM
|
|
Top-Line, Primary Outcomes, Secondary Outcomes, Exploratory Outcomes, and Alzheimer's/Cognitio...
|
8
|
Resverlogix Corp.
|
Jul 12, 2018 02:37PM
|
|
Danny Levine, The Bio Report Interview with Mark Day, Ph.D., President & CEO, Bioasis
|
5
|
BIOASIS TECHNOLOGIES INC
|
Jul 12, 2018 03:15PM
|
|
Re: Top-Line, Primary Outcomes, Secondary Outcomes, Exploratory Outcomes, and Alzheimer's/Cognitio...
|
6
|
Resverlogix Corp.
|
Jul 13, 2018 10:46AM
|
|
Re: It would be great if......
|
3
|
Resverlogix Corp.
|
Jul 16, 2018 09:56AM
|
|
Re: Safety, tolerability and efficacy for CKD and Fabry trials!
|
4
|
Resverlogix Corp.
|
Jul 16, 2018 10:33AM
|
|
Re: Riding the Xtandi coat tails
|
6
|
Zenith Epigenetics
|
Jul 16, 2018 10:52AM
|
|
Re: Bioasis announces intention of a non- brokered PP
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 16, 2018 11:07AM
|
|
Invokana CREDENCE Renal Outcomes Trial Stopped Early for Efficacy
|
4
|
Resverlogix Corp.
|
Jul 16, 2018 05:23PM
|
|
Re: Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conferenc
|
4
|
Resverlogix Corp.
|
Jul 17, 2018 10:23AM
|
|
Re: Riding the Xtandi coat tails
|
5
|
Zenith Epigenetics
|
Jul 17, 2018 02:38PM
|
|
Re: Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conferenc
|
3
|
Resverlogix Corp.
|
Jul 17, 2018 02:49PM
|
|
Re: Inflammation
|
2
|
Resverlogix Corp.
|
Jul 17, 2018 07:51PM
|
|
Re: DSMB 7th review??
|
5
|
Resverlogix Corp.
|
Jul 18, 2018 11:11AM
|
|
Resverlogix H2 2018 events
|
7
|
Resverlogix Corp.
|
Jul 18, 2018 12:14PM
|
|
Re: DSMB 7th review??
|
6
|
Resverlogix Corp.
|
Jul 18, 2018 11:41PM
|
